Name the exact medicine, form and reason for treatment
A brand name only starts the check. Mounjaro contains tirzepatide. Wegovy contains semaglutide. Foundayo contains orforglipron. Your prescription should name the product, strength, formulation and directions. Wegovy tablets and Wegovy injections are different formulations, and you cannot convert a tablet strength into an injection strength by comparing milligrams. A diabetes product containing semaglutide is no automatic swap for Wegovy.
For weight management in the UK, the licence and a clinical assessment decide what you can have. The MHRA authorised Wegovy tablets on 11 June 2026 for qualifying adults with obesity, or overweight with a weight-related condition, alongside diet and activity. The MHRA then authorised Foundayo on 10 August 2026 for weight management and type 2 diabetes. A licence tells you the approved uses. Stock, available strengths and NHS funding are questions for the pharmacy and your NHS team.
NHS treatment and private prescriptions work differently
Ask your NHS team which local pathway fits your reason for treatment. Referral, eligibility assessment and prescription are separate stages. National recommendations, local rollout and the services near you all shape what you get. Meeting the product licence does not mean the NHS will treat you straight away. A private prescription does not commit the NHS to continue your treatment later.
With private care, ask who assesses you, who prescribes and which pharmacy dispenses. These may be different organisations. A good service tells you what happens if treatment is unsuitable, what monitoring you get and how important information reaches your usual healthcare team. The questionnaire should let you give your full medical history. Never leave out another medicine, pregnancy plans or past side effects to get an automated approval.
Check the pharmacy and prescriber on the official registers
For a pharmacy in Great Britain, open the General Pharmaceutical Council register yourself and match the address and registration details to the dispensing pharmacy. Northern Ireland has its own regulator, the Pharmaceutical Society of Northern Ireland. A registration badge in a website footer proves nothing on its own. The business taking your payment and the registered pharmacy may trade under different names. Ask the service to explain the link.
Check the prescriber on the register for their profession. If a website says a clinician reviewed your application, you should know who is responsible for your care and how to reach the service. Look for a clear complaints process, privacy information and instructions for urgent help. Star ratings and social media praise do not replace these checks.
Compare the full ongoing cost
Ask for the full price at your prescribed strength, including consultation, dispensing, delivery and any recurring membership. A first-order discount may hide a different ongoing cost. Ask whether follow-up appointments are included, whether you pay to cancel and what happens if the prescriber turns you down after payment. Compare the same quantity over the same period. A four-week supply and a calendar-month subscription are not always the same thing.
If you switch providers, sort out continuity before your current supply runs out. Have your treatment history ready: the exact product, current strength, date of your last dose and any gaps. The new provider may need to reassess you. Do not order from several providers to build up extra stock, and do not combine prescriptions without their knowledge. A lower price still needs one joined-up clinical plan.
Delivery, storage and damaged parcels
Before you pay, ask how the medicine will travel and what the pharmacy wants you to do if the parcel is late, damaged or warm. Storage limits come from the exact product leaflet and the dispensing pharmacist. They differ by formulation, device and whether the medicine is open. A melted cold pack alone does not tell you whether the medicine is still usable.
If delivery goes wrong, keep the packaging and take photos. Note when the parcel arrived and when you contacted the pharmacy. Do not use a product with unclear identity, damage or storage history until the supplying pharmacist has assessed the problem. Tablets need proper storage too. Heat, moisture and repackaging still harm them, even without refrigerated delivery.
Travelling abroad with UK-prescribed treatment
A legitimate UK prescription does not give you the right to post the medicine overseas. Check the rules of your destination and any transit country, including personal import limits, quantity caps, paperwork and rules on needles or devices. Carry the medicine in its original labelled packaging with proof of your prescription. For longer trips, agree a plan with your clinician, including what to do about missed doses.
The UK authorisation announcements cited below are confirmed. For each current pack, age group, indication and local funding rule, read the current UK product information. The question to ask is whether this prescription can be supplied to you lawfully, appropriately and without gaps.
Sources
Your own medicine leaflet and prescriber come first. A source from another country does not mean the same rule applies in the UK.
- MHRA: GLP-1 medicines for weight loss and diabetes gov.uk
- MHRA: Wegovy tablet approval, 11 June 2026 gov.uk
- MHRA: Foundayo approval, 10 August 2026 gov.uk
- General Pharmaceutical Council registers pharmacyregulation.org
- Pharmaceutical Society of Northern Ireland psni.org.uk
Spotted something out of date? Report a mistake.